Bioequivalence Study of Morphine Sulfate 60 mg Extended-Release Tablets Under Fasting Conditions
NCT01665222 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 26
Last updated 2012-08-15
Summary
The study was to evaluate the relative bioavailability of morphine and morphine-6-glucuronide from 2 tablet products and determine if the 2 products were bioequivalent to each other.
Conditions
- Healthy
Interventions
- DRUG
-
Morphine Sulfate
Morphine Sulfate 60mg Extended-release tablets
Sponsors & Collaborators
-
Ranbaxy Inc.
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 20 Years
- Max Age
- 53 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2006-10-31
- Primary Completion
- 2006-10-31
- Completion
- 2006-12-31
More Related Trials
-
Study to Demonstrate the Bioequivalence of Single Oral Administration of K-001 Relative to Single Oral Coadministration of Separate Tablets of K-877-ER and CSG452
NCT05722262 ·Status: COMPLETED ·Phase: PHASE1
-
Single Dose Two-Way Crossover Fasted Bioequivalence Study of Nabumetone 750 mg Tablets in Healthy Volunteers
NCT00864968 ·Status: COMPLETED ·Phase: PHASE1
-
Comparison of One Morphine Sulfate Sustained-Release 200 mg Capsule With Two 100 mg KADIAN Capsules on Applesauce
NCT00759954 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence of BIBR 277 Tablet (Mannitol Based) Compared With Capsule Formulation in Healthy Male Volunteers
NCT02262585 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence Study of UH-AC 62 XX Tablets Compared With the Capsule Formulations in Healthy Volunteers
NCT02181907 ·Status: COMPLETED ·Phase: PHASE1
-
Comparison of Two KADIAN 10 mg Capsules to a KADIAN 20 mg Capsule Under Fasted Conditions
NCT00759902 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Assess Relative Bioavailability of GP681 Formulations in Healthy Chinese Male Subjects
NCT06678542 ·Status: COMPLETED ·Phase: PHASE1
-
A Bioavailability Crossover Study of Two Formulations of Lamotrigine Extended Release Tablets in Healthy Subjects
NCT02821338 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence of Oral Formulations of Anastrozole in Healthy Chinese Volunteers Under Fasted Condition
NCT04438733 ·Status: UNKNOWN ·Phase: PHASE1
-
The Bioequivalence Study of Lamotrigine Dispersible/Chewable Tablets 100mg Compared With Compressed Tablet 100 mg
NCT02064465 ·Status: COMPLETED ·Phase: PHASE1
-
Study of the Bioequivalence of the 20% and 30% Etoricoxib Tablet Formulations (0663-070)
NCT00945035 ·Status: COMPLETED ·Phase: PHASE1
-
The Bioequivalence Study of Lamotrigine Dispersible/Chewable Tablets 5mg×5 Compared With Lamotrigine Compressed Tablet 25mg in Chinese Healthy Male Subjects
NCT01879423 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence Study of Ezetimibe Tablets Under Fasting Conditions in Healthy Subjects
NCT05381870 ·Status: UNKNOWN ·Phase: PHASE1
-
Single Dose Two-Way Crossover Fed Bioequivalence Study of Nabumetone 750 mg Tablets in Healthy Volunteers
NCT00864604 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence of the Tablet and Liquid-Filled Capsule Forms of MK0974 (0974-042)
NCT00966030 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence Study of CJ-30060 in Healthy Volunteers
NCT03757390 ·Status: UNKNOWN ·Phase: PHASE1
-
An Open-label, Bioequivalence Study to Evaluate LEV Administered as a 45-min Intravenous Infusion and Same Dosage LEV Oral Tablet in Chinese
NCT01618903 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence Study of Lamotrigine Extended-Release Tablets 200mg Under Fed Condition
NCT01888263 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalency Study of Anastrozole 1 mg Under Fasted Conditions
NCT01155102 ·Status: COMPLETED ·Phase: NA
-
Bioequivalence Study of Pentoxifylline 400 Mg in Healthy Subjects Under Fasting and Fed Conditions
NCT06823362 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Bioequivalence Study of Torrent Pharmaceuticals Ltd's Bioequivalence Study of Torrent Pharmaceuticals Ltd's Quetiapine Tablets Under Fasting Conditions
NCT01634386 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Demonstrate Bioequivalence Between a 12-mg Dose of an Oral Suspension Formulation of Perampanel and a 12-mg Tablet Formulation of Perampanel Under Fasted and Fed Conditions in Healthy Subjects
NCT02279485 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence Study of Quetiapine Fumarate Tablets 300 mg Under Fasting Condition
NCT01566487 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence Study of CJ-30060 in Healthy Male Volunteers
NCT03639493 ·Status: COMPLETED ·Phase: PHASE1
-
A Bioequivalence Study Comparing Methylprednisolone Suspension to Methylprednisolone Tablets Under Fed Conditions
NCT01405170 ·Status: WITHDRAWN ·Phase: PHASE1